十一届新氧亚太医美行业盛典举办 “价值回归”已成行业核心共识

Core Insights - The 11th New Oxygen Asia-Pacific Aesthetic Medicine Industry Summit was held in Sanya, focusing on "value return" to reshape the technical value of doctors and promote high-quality industry development [1] - By 2025, the aesthetic medicine industry is expected to undergo structural changes, with an estimated 12,000 related enterprises being deregistered, a 50% increase compared to 2024, nearing historical peaks [1] - Consumers are increasingly rational, prioritizing qualifications, brand reputation, and professional expertise when choosing aesthetic institutions, with safety being the primary concern for treatment projects [1] Industry Trends - The aesthetic medicine market in China has reached a scale of hundreds of billions, expanding at a compound annual growth rate of 22.6%, making it one of the most promising core markets globally [2] - New Oxygen is leveraging its industrial platform and digital technology to implement "value return," enhancing service quality by curating high-quality merchants and streamlining SKUs to meet consumer demands for quality and diversity [2] - Despite the industry's transformation phase, there is a belief that the continuous release of aesthetic medicine demand will lead to new development opportunities, with a focus on maintaining medical value and team consensus during challenging external conditions [2] Event Highlights - The summit attracted nearly 400 industry representatives, including associations, brand institutions, and aesthetic doctors, and awarded over 260 prizes across 10 aesthetic medicine subfields [2]